Generali Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Sell
50,205
-899
-2% -$320K 0.37% 59
2025
Q4
$16.7M Buy
51,104
+12,414
+32% +$3.94M 0.34% 60
2025
Q3
$10.9M Buy
38,690
+1,097
+3% +$318K 0.23% 90
2025
Q2
$10.5M Sell
37,593
-867
-2% -$246K 0.24% 93
2025
Q1
$12M Sell
38,460
-22,384
-37% -$6.61M 0.3% 76
2024
Q4
$15.9M Buy
+60,844
New +$18.1M 0.41% 51

Other funds holding AMGN

Generali Asset Management's AMGN Position: Q1 2026 in Review

Generali Asset Management reduced its Amgen (AMGN) stake by 1.8% in Q1 2026, selling an estimated $320K and leaving 50,205 shares worth $17.7M. The position accounts for 0.37% of the portfolio, ranked #59.

Generali Asset Management first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Generali Asset Management held 50,205 shares of Amgen worth $17.7M as of Q1 2026.
  • Generali Asset Management sold 899 Amgen shares in Q1 2026, an estimated $320K.
  • Amgen made up 0.37% of Generali Asset Management's portfolio in Q1 2026, its #59 holding.
  • Generali Asset Management first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.